CJC-1295 with DAC Peptide – Research Grade Growth Hormone Releasing Hormone Analog
CJC-1295 with DAC is a synthetic peptide analog of growth hormone releasing hormone (GHRH) developed for laboratory research. The peptide incorporates a Drug Affinity Complex (DAC) which extends its half-life in research models, allowing for prolonged interaction with growth hormone releasing pathways.
In scientific research settings, CJC-1295 with DAC has been investigated for its potential influence on growth hormone signaling pathways, insulin-like growth factor (IGF-1) regulation, and endocrine system mechanisms. The extended activity provided by the DAC modification allows researchers to study long-acting GHRH analog behavior in controlled experimental environments.
Because of these characteristics, CJC-1295 with DAC has become a widely studied peptide in laboratory research exploring hormone signaling pathways and metabolic regulatory mechanisms.
Our CJC-1295 with DAC peptide is supplied as a high-purity lyophilised powder, manufactured under controlled laboratory conditions to ensure consistency, stability, and purity for scientific research applications.
Each vial contains 2mg of research-grade CJC-1295 with DAC peptide, sealed in a sterile glass vial to preserve peptide integrity. Lyophilisation helps maintain peptide stability during storage and transportation.
This compound is intended strictly for laboratory research purposes only and is not approved for human or veterinary use.